These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 9865302)

  • 61. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil--a prospective randomized study. Steroid Withdrawal Study Group.
    Ahsan N; Hricik D; Matas A; Rose S; Tomlanovich S; Wilkinson A; Ewell M; McIntosh M; Stablein D; Hodge E
    Transplantation; 1999 Dec; 68(12):1865-74. PubMed ID: 10628766
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Steroid-free immunosuppression in renal transplantation: a long-term follow-up of 100 consecutive patients.
    Birkeland SA
    Transplantation; 2001 Apr; 71(8):1089-90. PubMed ID: 11374407
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunosuppression protocols for HLA identical renal transplant recipients.
    Keitel E; Santos AF; Alves MA; Neto JP; Schaefer PG; Bittar AE; Goldani JC; Pozza R; Bruno RM; See D; Garcia CD; Garcia VD
    Transplant Proc; 2003 May; 35(3):1074-5. PubMed ID: 12947863
    [No Abstract]   [Full Text] [Related]  

  • 64. Mycophenolate mofetil in renal graft recipients with increased immune risk of graft loss.
    Boratyńska M; Magott M; Klinger M; Smolska D; Rychlewska B; Myszka K; Szepietowski T; Szyber P; Patrzalek D
    Transplant Proc; 2002 Mar; 34(2):553-5. PubMed ID: 12009621
    [No Abstract]   [Full Text] [Related]  

  • 65. Treatment of chronic rejection in renal transplantation by mycophenolate mofetil (MMF): a preliminary report of six-month experience.
    Jirasiritham S; Sumethkul V; Mavichak V; Jirasiritham S; Chiewsilp P; Leenanupunth C; Kochakarn W
    Transplant Proc; 1998 Nov; 30(7):3576-7. PubMed ID: 9838566
    [No Abstract]   [Full Text] [Related]  

  • 66. Prospective study of mycophenolate mofetil for the prevention of acute rejection in living donor renal allograft recipients.
    Park K; Kim SI; Moon JI; Kim YS; Kim MS
    Transplant Proc; 1998 Nov; 30(7):3575. PubMed ID: 9838565
    [No Abstract]   [Full Text] [Related]  

  • 67. Mycophenolate mofetil use is associated with prolonged graft survival after kidney transplantation.
    Kainz A; Heinze G; Korbély R; Schwarz C; Oberbauer R
    Transplantation; 2009 Nov; 88(9):1095-100. PubMed ID: 19898205
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Management of massive proteinuria following renal transplantation with mycophenolate mofetil and blood pressure normalization.
    Nakache R; Weinbroum A; Merhav H; Katz P; Kaplan E
    Transplant Proc; 2001 May; 33(3):2294-5. PubMed ID: 11377533
    [No Abstract]   [Full Text] [Related]  

  • 69. Mycophenolate mofetil and prednisone as maintenance treatment after kidney transplantation.
    van Gelder T; Klaassen RJ; van Riemsdijk-van Overbeeke I; IJzermans JN; Weimar W
    Transplantation; 1997 May; 63(10):1530-1. PubMed ID: 9175824
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Failure of ganciclovir prophylaxis of primary cytomegalovirus disease in immunologic high-risk recipients.
    Conti DJ; Isenberg A; Shen GK; Hahn A; Singh TP
    Transplant Proc; 1998 Jun; 30(4):1314-5. PubMed ID: 9636533
    [No Abstract]   [Full Text] [Related]  

  • 71. Treatment with mycophenolate mofetil in long-term renal transplant recipients: single-center experience in 28 patients.
    Djeffal R; Hiesse C; Kriaa F; Hafi A; Boubenider S; Ammor M; Durrbach A; Von Ey F; Droupy S; Hammoudi Y; Eschwege P; Benoît G; Charpentier B
    Transplant Proc; 2000 Dec; 32(8):2765-6. PubMed ID: 11134792
    [No Abstract]   [Full Text] [Related]  

  • 72. Lymphocyte subsets in renal transplant recipients treated with mycophenolate mofetil.
    François M; Büchler M; Halimi JM; Al-Najjar A; Valentin JF; Thibault G; Lebranchu Y
    Transplant Proc; 2000 Dec; 32(8):2781-2. PubMed ID: 11134803
    [No Abstract]   [Full Text] [Related]  

  • 73. Comparison of long-term actual renal allograft survival in mycophenolate mofetil and azathioprine-based triple drug immunosuppression protocols.
    Attallah N; Goggins M; Nori U; Abouljoud M; Zasuwa G; Venkat KK; Parasuraman R
    Transplant Proc; 2005 Jun; 37(5):2060-2. PubMed ID: 15964338
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Induction immunosuppressive therapy stratified according to risk categories in renal transplantation.
    Troncoso P; Ortiz AM; Jara A
    Transplant Proc; 2003 Nov; 35(7):2495-9. PubMed ID: 14611995
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Impact of immunosuppressive medication on the risk of renal allograft failure due to recurrent glomerulonephritis.
    Mulay AV; van Walraven C; Knoll GA
    Am J Transplant; 2009 Apr; 9(4):804-11. PubMed ID: 19353768
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Conversion from mycophenolate mofetil to azathioprine in high-risk renal allograft recipients on cyclosporine-based immunosuppression.
    Lou HX; Vathsala A
    Transplant Proc; 2004 Sep; 36(7):2090-1. PubMed ID: 15518756
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Role of immunosuppressive treatments based on mycophenolate mofetil in posttransplantation renal surgical complications.
    Herrero JC; Andrés A; Leiva O; Diaz R; Polo G; Aguirre F; Villacampa F; Rodicio JL; Gonzalez E; Morales JM; Praga M
    Transplant Proc; 2002 Feb; 34(1):96. PubMed ID: 11959201
    [No Abstract]   [Full Text] [Related]  

  • 78. The early impact of mycophenolate mofetil in combination with steroids and cyclosporine Neoral after renal transplantation: a six-month analysis.
    Cubas A; Herrero JC; Morales E; Carreño A; Dominguez-Gil B; Cirujeda A; Praga M; Ortuño T; Hernandez E; Delgado M; Andres A; Morales JM
    Transplant Proc; 1999 Sep; 31(6):2265-6. PubMed ID: 10500570
    [No Abstract]   [Full Text] [Related]  

  • 79. Mycophenolate mofetil prevents the progression of chronic kidney allograft nephropathy.
    Park JH; Park JH; Yang CW; Kim YS; Kim SY; Moon IS; Koh YB; Bang BK
    Transplant Proc; 2000 Nov; 32(7):1747. PubMed ID: 11119917
    [No Abstract]   [Full Text] [Related]  

  • 80. Reduced-dose cyclosporine with mycophenolate mofetil and prednisone significantly improves the long-term glomerular filtration rate and graft survival.
    Wang R; Xu Y; Wu J; Wang Y; He Q; Chen J
    Intern Med; 2013; 52(9):947-53. PubMed ID: 23648712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.